159 related articles for article (PubMed ID: 24175265)
41. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
Wirtz M; Helbig D
Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
[TBL] [Abstract][Full Text] [Related]
42. [Association of hypercalcemia, elevated levels of calcitriol and tuberculosis in patients on hemodialysis].
Peces R; Díaz Corte C
Nefrologia; 2000; 20(5):448-54. PubMed ID: 11100667
[TBL] [Abstract][Full Text] [Related]
43. Iatrogenic hypercalcemia in hemodialysis patients.
Muhammedi MA; Piraino B; Rault R; Johnston JR; Puschett JB
Clin Nephrol; 1991 Nov; 36(5):258-61. PubMed ID: 1752077
[TBL] [Abstract][Full Text] [Related]
44. A patient with sarcoidosis presenting with acute renal failure: implication for granulomatous interstitial nephritis and hypercalcemia.
Ohashi N; Yonemura K; Hirano M; Takahashi S; Kato A; Fujigaki Y; Yamamoto T; Hishida A
Intern Med; 2002 Dec; 41(12):1171-4. PubMed ID: 12521209
[TBL] [Abstract][Full Text] [Related]
45. Once weekly intravenous calcitriol suppresses hyperparathyroidism in hemodialysis patients.
Stim JA; Lowe J; Arruda JA; Dunea G
ASAIO J; 1995; 41(3):M693-8. PubMed ID: 8573894
[TBL] [Abstract][Full Text] [Related]
46. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
Sprague SM; Llach F; Amdahl M; Taccetta C; Batlle D
Kidney Int; 2003 Apr; 63(4):1483-90. PubMed ID: 12631365
[TBL] [Abstract][Full Text] [Related]
47. [Recurrence of sarcoidosis in a hemodialysis patient confirmed by abnormal calcium metabolism].
Tanaka K; Tanimoto H; Sakai K; Arai K; Mizuiri S; Hasegawa A; Otsuka T; Uchino M
Clin Calcium; 2005 Sep; 15 Suppl 1():83-5; discussion 86. PubMed ID: 16272637
[TBL] [Abstract][Full Text] [Related]
48. [Effect of calcitriol on secondary hyperparathyroidism].
Xu H; Zhang J; Cheng X; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
[TBL] [Abstract][Full Text] [Related]
50. BISPHOSPHONATES FOR THE TREATMENT OF CALCITRIOL-INDUCED HYPERCALCEMIA.
Mateo RCI; Ortiz R; Rosen HN
AACE Clin Case Rep; 2019; 5(5):e316-e320. PubMed ID: 31967061
[TBL] [Abstract][Full Text] [Related]
51. Hypercalcemia in Lung Cancer due to Simultaneously Elevated PTHrP and Ectopic Calcitriol Production: First Case Report.
Nemr S; Alluri S; Sundaramurthy D; Landry D; Braden G
Case Rep Oncol Med; 2017; 2017():2583217. PubMed ID: 28751994
[TBL] [Abstract][Full Text] [Related]
52. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis.
Shaker JL; Redlin KC; Warren GV; Findling JW
Am J Med Sci; 1994 Aug; 308(2):115-8. PubMed ID: 8042652
[TBL] [Abstract][Full Text] [Related]
53. Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism.
Pandey R; Zella J; Clagett-Dame M; Plum LA; DeLuca HF; Coyne DW
Am J Nephrol; 2016; 43(3):213-20. PubMed ID: 27096733
[TBL] [Abstract][Full Text] [Related]
54. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
[TBL] [Abstract][Full Text] [Related]
55. Correlates of parathyroid hormone concentration in hemodialysis patients.
Li J; Molnar MZ; Zaritsky JJ; Sim JJ; Streja E; Kovesdy CP; Salusky I; Kalantar-Zadeh K
Nephrol Dial Transplant; 2013 Jun; 28(6):1516-25. PubMed ID: 23348879
[TBL] [Abstract][Full Text] [Related]
56. Granulomatous mycosis fungoides.
Telle H; Koeppel MC; Jreissati M; Andrac L; Horschowski N; Sayag J
Eur J Dermatol; 1998; 8(7):506-10. PubMed ID: 9854165
[TBL] [Abstract][Full Text] [Related]
57. The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism.
Tsukamoto Y; Nomura M; Takahashi Y; Takagi Y; Yoshida A; Nagaoka T; Togashi K; Kikawada R; Marumo F
Nephron; 1991; 57(1):23-8. PubMed ID: 2046811
[TBL] [Abstract][Full Text] [Related]
58. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
[TBL] [Abstract][Full Text] [Related]
59. Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.
Fischer ER; Harris DC
Clin Nephrol; 1993 Oct; 40(4):216-20. PubMed ID: 8261678
[TBL] [Abstract][Full Text] [Related]
60. Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients.
Bechtel U; Mücke C; Feucht HE; Schiffl H; Sitter T; Held E
Am J Kidney Dis; 1995 Feb; 25(2):291-6. PubMed ID: 7847357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
